| Association of trypanolytic ApoL1 variants with kidney disease in African Americans G Genovese, DJ Friedman, MD Ross, L Lecordier, P Uzureau, ... Science 329 (5993), 841-845, 2010 | 2126 | 2010 |
| VEGF inhibition and renal thrombotic microangiopathy V Eremina, JA Jefferson, J Kowalewska, H Hochster, M Haas, J Weisstuch, ... New England Journal of Medicine 358 (11), 1129-1136, 2008 | 1756 | 2008 |
| Enzyme replacement therapy in Fabry disease: a randomized controlled trial R Schiffmann, JB Kopp, HA Austin III, S Sabnis, DF Moore, T Weibel, ... Jama 285 (21), 2743-2749, 2001 | 1652 | 2001 |
| Identification of renox, an NAD (P) H oxidase in kidney M Geiszt, JB Kopp, P Várnai, TL Leto Proceedings of the National Academy of Sciences 97 (14), 8010-8014, 2000 | 1076 | 2000 |
| Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. N Sanderson, V Factor, P Nagy, J Kopp, P Kondaiah, L Wakefield, ... Proceedings of the National Academy of Sciences 92 (7), 2572-2576, 1995 | 916 | 1995 |
| TGF-β and fibrosis MH Branton, JB Kopp Microbes and infection 1 (15), 1349-1365, 1999 | 912 | 1999 |
| APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy JB Kopp, GW Nelson, K Sampath, RC Johnson, G Genovese, P An, ... Journal of the American Society of Nephrology 22 (11), 2129-2137, 2011 | 897 | 2011 |
| Apoptosis in podocytes induced by TGF-β and Smad7 M Schiffer, M Bitzer, ISD Roberts, JB Kopp, P ten Dijke, P Mundel, ... The Journal of clinical investigation 108 (6), 807-816, 2001 | 847 | 2001 |
| MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis JB Kopp, MW Smith, GW Nelson, RC Johnson, BI Freedman, DW Bowden, ... Nature genetics 40 (10), 1175-1184, 2008 | 842 | 2008 |
| APOL1 risk variants, race, and progression of chronic kidney disease A Parsa, WHL Kao, D Xie, BC Astor, M Li, C Hsu, HI Feldman, RS Parekh, ... New England Journal of Medicine 369 (23), 2183-2196, 2013 | 800 | 2013 |
| CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility JM Kim, H Wu, G Green, CA Winkler, JB Kopp, JH Miner, ER Unanue, ... Science 300 (5623), 1298-1300, 2003 | 674 | 2003 |
| Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator A Cheruvanky, H Zhou, T Pisitkun, JB Kopp, MA Knepper, PST Yuen, ... American Journal of Physiology-Renal Physiology 292 (5), F1657-F1661, 2007 | 606 | 2007 |
| Focal segmental glomerulosclerosis AZ Rosenberg, JB Kopp Clinical Journal of the American Society of Nephrology 12 (3), 502-517, 2017 | 597 | 2017 |
| Natural history of Fabry renal disease: influence of α-galactosidase A activity and genetic mutations on clinical course MH Branton, R Schiffmann, SG Sabnis, GJ Murray, JM Quirk, G Altarescu, ... Medicine 81 (2), 122-138, 2002 | 588 | 2002 |
| Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease K Sharma, B Karl, AV Mathew, JA Gangoiti, CL Wassel, R Saito, M Pu, ... Journal of the American Society of Nephrology 24 (11), 1901-1912, 2013 | 580 | 2013 |
| Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. JB Kopp, VM Factor, M Mozes, P Nagy, N Sanderson, EP Böttinger, ... Laboratory investigation; a journal of technical methods and pathology 74 (6 …, 1996 | 578 | 1996 |
| The Notch pathway in podocytes plays a role in the development of glomerular disease T Niranjan, B Bielesz, A Gruenwald, MP Ponda, JB Kopp, DB Thomas, ... Nature medicine 14 (3), 290-298, 2008 | 500 | 2008 |
| Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States C Kitiyakara, P Eggers, JB Kopp American Journal of Kidney Diseases 44 (5), 815-825, 2004 | 406 | 2004 |
| Crystalluria and urinary tract abnormalities associated with indinavir JB Kopp, KD Miller, JAM Mican, IM Feuerstein, E Vaughan, C Baker, ... Annals of internal medicine 127 (2), 119-125, 1997 | 386 | 1997 |
| Podocytopathies JB Kopp, HJ Anders, K Susztak, MA Podestà, G Remuzzi, F Hildebrandt, ... Nature Reviews Disease Primers 6 (1), 68, 2020 | 376 | 2020 |
Avi Z. RosenbergJohns Hopkins University-School of MedicineVerified email at jhmi.edu
